An expert in CRISPR genome editing, NemaMetrix creates custom genome edited C. elegans and zebrafish models to enable aging, developmental and disease studies. NemaMetrix also develops and manufactures genotyping and phenotyping products, including instruments, reagents and consumables to allow researchers to explore and discover new phenotypes. In addition, NemaMetrix provides essential services to produce data and insights for companies that need to make go/no-go decisions quickly, and advance the discovery and early-stage development of new compounds.
Meet Our Leadership Team
As the CEO, Matt Beaudet brings over 18 years in development leadership in creating platforms for the biotechnology and drug discovery markets.
As the inventor of our core system, Shawn brings his expertise in C. elegans, neurophysiology, and microfluidics for biological applications.
Dr. Turner founded Pacific Biosciences and served as CEO until 2004. He presently serves as CTO of Pacific Biosciences. He is the author of over 50 scientific papers in fields ranging from DNA sequencing technology and biophysics to genomics and epigenomics. He holds over 100 U.S. patents.
Wenlan brings a wide range of experience in brand and product marketing, integrated marketing communications, marketing operations, and financial analysis from the biotech and IT industries.
VP of Operations
Brian brings more than 20 years of experience in Operations Management and operational performance including Lean Manufacturing, Six-Sigma and Quality Engineering in the Biotech industry. He has led teams ranging from product packaging to fine chemical manufacturing to antibody and immunology consumables production.